4/A//SEC Filing
GAUSLING MICHAEL J 4/A
Accession 0001192482-18-000106
CIK 0001651561other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 3:01 PM ET
Size
12.2 KB
Accession
0001192482-18-000106
Insider Transaction Report
Form 4/AAmended
GAUSLING MICHAEL J
10% Owner
Transactions
- Sale
Common Stock
2017-12-08$25.85/sh−523,085$13,521,747→ 1,390,273 total(indirect: By: Originate Growth Fund #1Q, L.P.) - Sale
Common Stock
2017-12-11$25.85/sh−160,375$4,145,694→ 1,229,898 total(indirect: By: Originate Growth Fund #1Q, L.P.) - Sale
Common Stock
2017-12-08$25.85/sh−237,195$6,131,491→ 629,594 total(indirect: By: Originate Growth Fund #1A, L.P.) - Sale
Common Stock
2017-12-11$25.85/sh−72,625$1,877,356→ 556,969 total(indirect: By: Originate Growth Fund #1A, L.P.)
Holdings
- 8,000
Common Stock
Footnotes (5)
- [F1]Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- [F2]Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- [F3]Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- [F4]Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- [F5]The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.
Documents
Issuer
Tabula Rasa HealthCare, Inc.
CIK 0001651561
Entity typeother
Related Parties
1- filerCIK 0001125761
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 3:01 PM ET
- Size
- 12.2 KB